or Try an Advanced Search...

    ETF Components for FSZ - First Trust Switzerland AlphaDex Fund


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    ABBV F 1.88 4.18
    NVS D 0.13 2.40
    LOGI F 1.45 1.34

    Represented by ETF Holdings

    Keywords: Eye Care Products Pharmaceutical Active Pharmaceutical Ingredients Adalimumab Advanced Prostate Cancer Anemia Animal Health Antibiotics Atopic Dermatitis Audiovisual Autoimmune Disease Biotechnology Blood Cancers Blood Test Chronic Idiopathic Constipation Combination Drugs Communication Products Constipation Contact Lens Contact Lenses
    Industries: Drug Manufacturers - Major Computer Systems

    Recent News for First Trust Switzerland AlphaDex Fund & its Holdings

    Date Stock Title
    Nov 20 LOGI Logitech slips even as UBS upgrades on 'balanced' risk-reward
    Nov 20 ABBV Unpacking the Latest Options Trading Trends in AbbVie
    Nov 19 ABBV ALDX Up as FDA Accepts Resubmitted NDA for Eye Drug Reproxalap
    Nov 19 ABBV Where Will AbbVie Be in 5 Years?
    Nov 19 NVS Novartis ranks first in 2024 Access to Medicine Index
    Nov 19 NVS Novartis strengthens radiopharma leadership with Ratio Therapeutics deal
    Nov 19 NVS Astellas application rejected by FDA; Cytokinetics strikes licensing deal with Bayer
    Nov 19 ABBV RVPH: Year-End OLE Update
    Nov 19 ABBV What is a ‘cure,’ really? AbbVie’s Humira creator leaps into the next phase of medicine
    Nov 18 ABBV AbbVie snaps eight straight sessions of losses
    Nov 18 NVS Novartis, Ratio to collaborate on SSTR2 radiotherapeutic for cancer
    Nov 18 ABBV Aldeyra announces FDA acceptance of resubmitted reproxalap application
    Nov 18 ABBV AbbVie's Ovarian Cancer Drug Elahere Gets Approval in Europe
    Nov 18 NVS Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
    Nov 18 ABBV Allergan Aesthetics Offers Free Business Education Courses Online to Support Growing Practices with Allergan Aesthetics Products
    Nov 18 NVS Ratio Enters License and Collaboration Agreement with Novartis for SSTR2-targeting Radiotherapeutic Candidate
    Nov 18 ABBV AbbVie’s Elahere wins European approval for certain ovarian cancers
    Nov 18 ABBV Why This Beaten-Down Dividend Stock Is a No-Brainer Buy on the Dip
    Nov 18 ABBV AbbVie Receives European Commission Approval of ELAHERE® (mirvetuximab soravtansine) for the Treatment of Platinum-Resistant Ovarian Cancer
    Nov 17 ABBV Super Micro Computer, Moderna And XPeng Were Among Top 10 Large Cap Stocks Losing Big Last Week (November 11-15): Check Out Other Losers
    The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the Defined Switzerland Index. The fund will normally invest at least 90% of its net assets plus the amount of any borrowings for investment purposes in stocks and/or depositary receipts that comprise the index. It, using an "indexing" investment approach, attempts to replicate, before fees and expenses, the performance of the index. The index is designed by S&P to objectively identify and select securities from the S&P Switzerland BMI Index. The fund is non-diversified.
    Exchange Traded Fund ETF Index Fund Stock Market Index S&P Sri Lanka 20 Index (Lkr) Switzerland Index
    Back to the Main FSZ Page...